Nathaniel Lacktman Calls for Swift Action on Remote Prescribing Rules Under New Administration
Foley & Lardner LLP partner Nathaniel Lacktman described the need for quick action under the new Trump administration on flexibilities for telemedicine prescribing in the Modern Healthcare article, “3 Biden healthcare regulations Trump will have to finalize.”
Lacktman, chair of Foley’s national Telemedicine & Digital Health Industry Team, said that failing any new steps taken by the U.S. Drug Enforcement Administration, the Trump administration should move promptly on the issue, and ideally in collaboration with Congress.
Lacktman noted that the first Trump administration was “bullish” on policies that promote telemedicine and digital health, an example being the permanent expansion of Medicare telehealth services in 2020, and he explained that this suggests President Trump’s second term will be amenable to the industry’s hopes for favorable regulations.
Lacktman’s commentary also appeared in Advisory Board.
(Subscription required)
For more information on telemedicine, telehealth, virtual care, remote patient monitoring, digital health, and other health innovations, including the team, publications, and representative experience, visit Foley’s Telemedicine & Digital Health Industry Team.
